Example: Heart Attack

Clinical Trials on Adrenocortical Carcinoma

Total 95 results

NCT06050057

Recruiting

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Cushing Syndrome | Pheochromocytoma | Adrenocortical Carcinoma | Adrenal Cortex Diseases | Adrenocortical Adenoma | Adrenal Tumor | Adrenalectomy; Status | Adrenal Mass | Adrenal Hyperplasia | Adrenal Disease
NCT06041516

Not yet recruiting

Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Neuroendocrine Tumors | Carcinoma, Neuroendocrine | Neuroendocrine Carcinomas | Carcinoma, Adrenal Cortical | Carcinoma, Adrenocortical
NCT06006013

Not yet recruiting

Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Locally Advanced Adrenal Cortical Carcinoma | Metastatic Adrenal Cortical Carcinoma | Stage III Adrenal Cortical Carcinoma AJCC v8 | Stage IV Adrenal Cortical Carcinoma AJCC v8 | Unresectable Adrenal Cortical Carcinoma
NCT05999292

Recruiting

Phase 1 Study of 68Ga-R8760

Adrenocortical Carcinoma
NCT05913427

Recruiting

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC) (PESETA)

Adrenocortical Carcinoma
NCT05839886

Not yet recruiting

The Adverse Event of Mitotane Therapy in Patients With Adrenocortical Carcinoma (MEET)

Adrenocortical Carcinoma
NCT05763524

Recruiting

European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma (LACC)

Adrenocortical Carcinoma
NCT05660889

Recruiting

Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma (AVS for ACC)

Adrenocortical Carcinoma
NCT05638269

Recruiting

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Epilepsy | Chronic Kidney Diseases | Nasopharyngeal Cancer | Gastric Cancer | Pancreatic Cancer | Lung Cancer | Essential Hypertension | Acute Coronary Syndrome | Primary Aldosteronism | Liver Cancer
NCT05634577

Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Adrenocortical Carcinoma
NCT05563467

Recruiting

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. (PEMBR-01)

Adrenocortical Carcinoma
NCT05237934

Recruiting

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Neuroendocrine Tumors | Carcinoma, Neuroendocrine
NCT05036434

Not yet recruiting

Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma (ACCOMPLISH)

Adrenocortical Carcinoma
NCT04897321

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Melanoma | Soft Tissue Sarcoma | Carcinoma | Osteosarcoma | Ewing Sarcoma | Rhabdoid Tumor | Neuroblastoma | Rhabdomyosarcoma | Wilms Tumor | Hepatoblastoma
NCT04890444

Recruiting

China Adrenal Disease Registry (CASE)

Congenital Adrenal Hyperplasia | Cushing Syndrome | Pheochromocytoma | Adrenal Incidentaloma | Adrenal Adenoma | Adrenal Carcinoma | Aldosteronism | Hypoadrenalism
NCT04666220

Recruiting

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

Renal Cell Carcinoma | Adrenal Carcinoma
NCT04318730

Recruiting

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Adrenocortical Carcinoma
NCT04187404

Recruiting

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (Spencer)

Pheochromocytoma | Paraganglioma | Adrenocortical Carcinoma
NCT03833700

Recruiting

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

Colorectal Neoplasms | Gastrointestinal Tumors | Solid Neoplasms
NCT03746431

Recruiting

A Phase 1/2 Study of [225Ac]-FPI-1434 Injection

Cervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer | Uveal Melanoma | Adrenocortical Carcinoma | Advanced Solid Tumours | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT03612232

Recruiting

Cabozantinib in Advanced Adrenocortical Carcinoma (CaboACC)

Adrenocortical Carcinoma
NCT03583710

Recruiting

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

ENSAT Stage I Adrenal Cortex Carcinoma | ENSAT Stage II Adrenal Cortex Carcinoma | ENSAT Stage III Adrenal Cortex Carcinoma
NCT03127774

Recruiting

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Peritoneal Carcinomatosis | Adrenocortical Carcinoma
NCT03050268

Recruiting

Familial Investigations of Childhood Cancer Predisposition (SJFAMILY)

Pancreatic Cancer | Hodgkin Lymphoma | Lynch Syndrome | Tuberous Sclerosis | Fanconi Anemia | AML | Non Hodgkin Lymphoma | Familial Adenomatous Polyposis | Acute Leukemia | Nevoid Basal Cell Carcinoma Syndrome
NCT02324647

Recruiting

Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield (SERENDIPITY)

Adrenocortical Carcinoma | Adrenal Incidentaloma
NCT00669266

Recruiting

Adrenal Tumors - Pathogenesis and Therapy

Cushing Syndrome | Pheochromocytoma | Adrenocortical Carcinoma | Conn Syndrome | Adrenal Tumors
NCT00457587

Recruiting

Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

Cushing's Syndrome | Adrenocortical Carcinoma
NCT00453674

Recruiting

German Adrenocortical Carcinoma Registry

Adrenocortical Carcinoma
NCT04358107

Active, not recruiting

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Adrenocortical Carcinoma
NCT02834013

Active, not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Malignant Solid Neoplasm | Nasopharyngeal Carcinoma | Adenoid Cystic Carcinoma | Transitional Cell Carcinoma | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Chordoma | Gestational Trophoblastic Tumor | Pseudomyxoma Peritonei | Cervical Adenocarcinoma
NCT00304070

Completed

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor

Stage I Adrenal Cortical Carcinoma AJCC v7 | Stage II Adrenal Cortical Carcinoma AJCC v7 | Stage III Adrenal Cortical Carcinoma AJCC v7 | Stage IV Adrenal Cortical Carcinoma AJCC v7
NCT03604198

Enrolling by invitation

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Cushing Syndrome
NCT05012397

Active, not recruiting

Milademetan in Advanced/Metastatic Solid Tumors

Melanoma | Sarcoma | Cervical Cancer | Testicular Germ Cell Tumor | Gastric Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Lung Adenocarcinoma | Solid Tumors | Pancreas Cancer
NCT04373265

Active, not recruiting

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

Adrenocortical Carcinoma
NCT03333616

Active, not recruiting

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Adrenocortical Carcinoma | Penile Cancer | Genitourinary Cancer | Non-urothelial Bladder | Non-urothelial Upper Tract | Non-adenocarcinoma Prostate Cancer | Refractory Germ-cell | High Grade Neuroendocrine Carcinoma/Small Cell Carcinoma
NCT02721732

Active, not recruiting

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Skin Squamous Cell Carcinoma | Unresectable Solid Neoplasm | Metastatic Kidney Medullary Carcinoma | Metastatic Penile Carcinoma | Small Cell Carcinoma | Metastatic Adrenal Gland Pheochromocytoma | Stage IV Penile Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7
NCT02673333

Active, not recruiting

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Adrenocortical Carcinoma
NCT04447014

Terminated

Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)

Adrenocortical Carcinoma | Adrenocortical Cancer
NCT03370718

Active, not recruiting

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Metastatic Carcinoma in the Adrenal Cortex | Stage III Adrenal Cortex Carcinoma AJCC v8 | Stage IV Adrenal Cortex Carcinoma AJCC v8 | Unresectable Adrenal Cortex Carcinoma
NCT02867592

Active, not recruiting

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Soft Tissue Sarcoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Osteosarcoma | Ewing Sarcoma | Recurrent Renal Cell Carcinoma | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma
NCT05361083

Completed

First-in-human Evaluation of [18F]CETO

Adrenocortical Carcinoma | Adrenal Cushing Syndrome | Primary Aldosteronism Due to Aldosterone Producing Adenoma | Primary Aldosteronism Due to Nodular Hyperplasia | Non-Secretory Adrenal Adenoma
NCT05344027

Active, not recruiting

The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma (MitoS-FP)

Adrenocortical Carcinoma
NCT02637531

Active, not recruiting

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Advanced Solid Tumors (Part A/B/C/D) | Non-small Cell Lung Cancer (Part E) | Melanoma (Part E) | Squamous Cell Cancer of the Head and Neck (Part E) | Triple Negative Breast Cancer (Part F) | Adrenocortical Carcinoma (Part G) | Mesothelioma (Part G) | High-circulating Myeloid-derived Suppressor Cells (Part H)
NCT01772004

Completed

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Solid Tumors
NCT02468193

Completed

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Cushing's Syndrome | Ectopic Corticotropin Syndrome | Adrenal Adenoma | Adrenal Carcinoma | AIMAH | PPNAD
NCT03474237

Enrolling by invitation

A Prospective Cohort Study for Patients With Adrenal Diseases

Cushing Syndrome | Pheochromocytoma | Primary Hyperaldosteronism | Adrenocortical Carcinoma | Adrenal Incidentaloma | Adrenal Adenoma
NCT02015026

Completed

Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma

Adrenocortical Carcinoma
NCT02804750

Completed

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

Cushing's Syndrome
NCT02672020

Completed

Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card (COMETETACTIC)

Adrenal Gland Neoplasms
NCT01833832

Completed

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

Peritoneal Carcinomatosis | Adrenocortical Carcinoma

Clinical Trials on Adrenocortical Carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations